Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-03-26 @ 3:17 PM
NCT ID: NCT07487532
Eligibility Criteria: Inclusion Criteria: * Age 20 to 75 years Persistent atrial fibrillation Undergoing first-time catheter ablation with successful restoration of sinus rhythm Left atrial diameter \<50 mm Able to understand the study and provide written informed consent Exclusion Criteria: * Cardiovascular events within the past 3 months (including stroke, transient ischemic attack, myocardial infarction, unstable angina, or cardiac surgery) Symptomatic hypotension with systolic blood pressure \<100 mmHg on two consecutive measurements Severe valvular heart disease or other significant structural heart disease Pregnancy, breastfeeding, or planned pregnancy during the study period History of pacemaker implantation Second- or third-degree atrioventricular block Bifascicular or trifascicular block Acupuncture treatment for cardiovascular disease within the past 3 months Severe comorbid conditions, including: Malignant tumors Chronic infectious diseases Severe renal dysfunction (eGFR \<30 mL/min/1.73 m² or requiring dialysis) Moderate to severe liver dysfunction (Child-Pugh class B or C) Anemia (hemoglobin \<90 g/L) Systemic diseases requiring steroid therapy Severe cognitive impairment or dementia Alcohol or substance abuse Life expectancy \<12 months Poor compliance or inability to provide informed consent Participation in another interventional clinical study
Healthy Volunteers: False
Sex: ALL
Minimum Age: 20 Years
Maximum Age: 75 Years
Study: NCT07487532
Study Brief:
Protocol Section: NCT07487532